www.fdanews.com/articles/61152-onyx-drug-gets-european-approval
ONYX DRUG GETS EUROPEAN APPROVAL
July 25, 2006
Onyx Pharmaceuticals Inc. and Bayer Pharmaceuticals Corp. have received the
European Commission's authorization to market their kidney cancer drug, the
two companies announced. Emeryville-based Onyx and Bayer, based in West Haven,
Conn., are codeveloping the drug under an agreement where they share varying
costs and profits in different locations. Bayer is commercializing Nexavar in
Europe.
Business
Times